» Articles » PMID: 35536529

Evaluation of Tea (Camellia Sinensis L.) Phytochemicals As Multi-disease Modulators, a Multidimensional in Silico Strategy with the Combinations of Network Pharmacology, Pharmacophore Analysis, Statistics and Molecular Docking

Overview
Journal Mol Divers
Date 2022 May 10
PMID 35536529
Authors
Affiliations
Soon will be listed here.
Abstract

Tea (Camellia sinensis L.) is considered as to be one of the most consumed beverages globally and a reservoir of phytochemicals with immense health benefits. Despite numerous advantages, tea compounds lack a robust multi-disease target study. In this work, we presented a unique in silico approach consisting of molecular docking, multivariate statistics, pharmacophore analysis, and network pharmacology approaches. Eight tea phytochemicals were identified through literature mining, namely gallic acid, catechin, epigallocatechin gallate, epicatechin, epicatechin gallate (ECG), quercetin, kaempferol, and ellagic acid, based on their richness in tea leaves. Further, exploration of databases revealed 30 target proteins related to the pharmacological properties of tea compounds and multiple associated diseases. Molecular docking experiment with eight tea compounds and all 30 proteins revealed that except gallic acid all other seven phytochemicals had potential inhibitory activities against these targets. The docking experiment was validated by comparing the binding affinities (Kcal mol) of the compounds with known drug molecules for the respective proteins. Further, with the aid of the application of statistical tools (principal component analysis and clustering), we identified two major clusters of phytochemicals based on their chemical properties and docking scores (Kcal mol). Pharmacophore analysis of these clusters revealed the functional descriptors of phytochemicals, related to the ligand-protein docking interactions. Tripartite network was constructed based on the docking scores, and it consisted of seven tea phytochemicals (gallic acid was excluded) targeting five proteins and ten associated diseases. Epicatechin gallate (ECG)-hepatocyte growth factor receptor (PDB id 1FYR) complex was found to be highest in docking performance (10 kcal mol). Finally, molecular dynamic simulation showed that ECG-1FYR could make a stable complex in the near-native physiological condition.

Citing Articles

Revealing the role of metformin in gastric intestinal metaplasia treatment.

Hu R, Xue X, Sun X, Mi Y, Wen H, Xi H Front Pharmacol. 2024; 15:1340309.

PMID: 39101145 PMC: 11294171. DOI: 10.3389/fphar.2024.1340309.


Synthesis and Isolation of Phenol- and Thiol-Derived Epicatechin Adducts Prepared from Avocado Peel Procyanidins Using Centrifugal Partition Chromatography and the Evaluation of Their Antimicrobial and Antioxidant Activity.

Berrios-Henriquez B, Venegas-Toloza M, Reyes-Fuentes M, Zuniga-Arbalti F, Bustamante L, Garcia-Cancino A Molecules. 2024; 29(12).

PMID: 38930937 PMC: 11206461. DOI: 10.3390/molecules29122872.


Network pharmacology and molecular docking: combined computational approaches to explore the antihypertensive potential of Fabaceae species.

Shahzadi Z, Yousaf Z, Anjum I, Bilal M, Yasin H, Aftab A Bioresour Bioprocess. 2024; 11(1):53.

PMID: 38767701 PMC: 11106056. DOI: 10.1186/s40643-024-00764-6.


Evaluation of therapeutic potentials of selected phytochemicals against Nipah virus, a multi-dimensional in silico study.

Rababi D, Nag A 3 Biotech. 2023; 13(6):174.

PMID: 37180429 PMC: 10170460. DOI: 10.1007/s13205-023-03595-y.


Antidiabetic Actions of Ethanol Extract of Leaf Ameliorates Insulin Secretion, Inhibits the DPP-IV Enzyme, Improves Glucose Tolerance, and Increases Active GLP-1 (7-36) Levels in High-Fat-Diet-Fed Rats.

Ansari P, Hannan J, Choudhury S, Islam S, Talukder A, Seidel V Medicines (Basel). 2022; 9(11).

PMID: 36422117 PMC: 9698069. DOI: 10.3390/medicines9110056.

References
1.
Kim S, Thiessen P, Bolton E, Chen J, Fu G, Gindulyte A . PubChem Substance and Compound databases. Nucleic Acids Res. 2015; 44(D1):D1202-13. PMC: 4702940. DOI: 10.1093/nar/gkv951. View

2.
Sanchez M, Gonzalez-Burgos E, Iglesias I, Lozano R, Gomez-Serranillos M . The Pharmacological Activity of (‎L.‎) ‎Kuntze‎ on Metabolic and Endocrine Disorders: A Systematic Review. Biomolecules. 2020; 10(4). PMC: 7226397. DOI: 10.3390/biom10040603. View

3.
Yu J, Chen G, Lai P . Targeting hepatocyte growth factor/c-mesenchymal-epithelial transition factor axis in hepatocellular carcinoma: Rationale and therapeutic strategies. Med Res Rev. 2020; 41(1):507-524. DOI: 10.1002/med.21738. View

4.
Badalamenti N, Sottile F, Bruno M . Ethnobotany, Phytochemistry, Biological, and Nutritional Properties of Genus -A Review. Plants (Basel). 2022; 11(4). PMC: 8875603. DOI: 10.3390/plants11040519. View

5.
Wishart D, Knox C, Guo A, Cheng D, Shrivastava S, Tzur D . DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2007; 36(Database issue):D901-6. PMC: 2238889. DOI: 10.1093/nar/gkm958. View